Company news

Veracyte, Inc. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Veracyte Announces Novel Gene Fusion Detection with the Afirma Xpression Atlas, Which May Inform Targeted Treatment Decisions for Thyroid Cancer Patients

March 31, 2020

Veracyte Announces Publication of Nearly 700-Patient Study Using Prosigna Breast Cancer Test to Identify Patients Likely to Benefit from Aggressive Chemotherapy

March 1, 2020

Veracyte Announces Fourth Quarter and Full-Year 2019 Financial Results and Provides 2020 Financial Outlook

February 24, 2020

Veracyte to Release Fourth Quarter and Full-Year 2019 Financial Results on February 25, 2020

February 5, 2020

Veracyte Announces Biopharmaceutical Collaboration with Acerta Pharma

January 7, 2020

Veracyte Acquires Exclusive License to NanoString Diagnostics Platform, Positioning Veracyte To Expand Its Genomic Testing Business Globally

December 2, 2019

Veracyte Announces New Data That Advance Understanding of Genomic Alterations Targeted by Precision Medicine Therapies for Thyroid Cancer

November 1, 2019

Veracyte Announces New Data Characterizing Genomic Alterations in Thyroid Cancer To Be Presented at 89th Annual Meeting of the American Thyroid Association

October 29, 2019

Veracyte Announces Third Quarter 2019 Financial Results and Business Progress

October 21, 2019

Veracyte Announces Clinical Data Demonstrating Clinical Validity and Utility of Percepta Classifier in Lung Cancer Diagnosis When Bronchoscopy Results Are Inconclusive

October 20, 2019

Veracyte Announces Publication of Clinical and Analytical Validation Data for Afirma Xpression Atlas

September 10, 2019

← Newer news releases

Calls

The 5 newest of 25 calls. Every call is listed under its year.

Decks

The 5 newest of 19 decks. Every deck is listed under its year.